Eco R1 Capital, LLC Sangamo Therapeutics, Inc Transaction History

Eco R1 Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $14.3 Million - $27.3 Million	-2,308,079 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $11.7 Million - $20.4 Million	2,308,079 New	2,308,079 $14.7 Million
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $9.15 Million - $15.2 Million	-1,185,831 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $8.01 Million - $14 Million	842,600 Added 245.49%	1,185,831 $13.6 Million
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $15.2 Million - $22.2 Million	-1,166,440 Reduced 77.26%	343,231 $5.82 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $21 Million - $29.9 Million	1,509,671 New	1,509,671 $21.4 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $2.58 Million - $3.86 Million	-222,388 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $1.87 Million - $3.34 Million	222,388	222,388 $3.34 Million

136

51M

2.17M

1.82M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $78.3M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.